Latest (Dec 2023) Quarterly:
"Regulatory activities continue to progress
EBR made significant progress regarding key regulatory activities during the quarter. Following the Company’s update in November 2023, EBR is scheduled to submit the final module of its PMA submission in Q3 2024 and is targeting FDA approval in Q1 2025."
Latest (Dec 2023) Quarterly:"Regulatory activities continue to...
Add EBR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
99.0¢ |
Change
0.025(2.59%) |
Mkt cap ! $305.0M | |||
| Open | High | Low | Value | Volume |
| $1.01 | $1.01 | 98.0¢ | $162.4K | 163.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 15000 | 98.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 99.0¢ | 58931 | 1 |
View Market Depth
| Last trade - 15.59pm 13/05/2024 (20 minute delay) ? |
|
|||||
|
Last
99.0¢ |
Change
0.025 ( 0.11 %) |
||||
| Open | High | Low | Volume | ||
| $1.01 | $1.01 | 98.0¢ | 29685 | ||
| Last updated 15.59pm 13/05/2024 ? | |||||
| EBR (ASX) Chart |